Chief operating officer, Scholar Rock
Appears in 1 story
Running the commercial launch of Isembyld
Patients with spinal muscular atrophy (SMA) have had drugs that keep motor neurons alive for a decade. None stopped the muscle wasting that defines advanced disease. On September 11, 2026, the FDA approved the first treatment built to do that.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
